Is Retzius-sparing radical prostatectomy the surgical wave of the future?

Back in the early 1980s, Dr. Patrick Walsh at the Johns Hopkins Medical Center in Baltimore changed the nature of surgical treatment for prostate cancer when he first started to conduct so-called nerve-sparing radical prostatectomies. … READ MORE …

Pre-surgical weight loss in the surgical treatment of prostate cancer

Overweight and obese prostate cancer patients are often advised to lose weight prior to surgery for the treatment of localized forms of prostate cancer. But is this really, always, a good idea? … READ MORE …

The end to WHAT controversy?

In an extraordinary editorial in the July issue of the Journal of Urology, Dr. Michael Koch of the University of Indiana School of Medicine makes the following statement: … READ MORE …

Early, adjuvant chemotherapy in high-risk patients after surgery

A paper presented yesterday at the now-completed annual meeting of the American Urological Association has given us new data on the role of adjuvant chemotherapy alone in the treatment of men with high-risk prostate cancer. … READ MORE …

Is salvage radical prostatectomy really being under-used?

A new paper in the journal Clinical Genitourinary Cancer states that, “Salvage radical prostatectomy (SRP) is a treatment modality for patients with radio-recurrent prostate cancer but is currently underutilized.” The “New” Prostate Cancer InfoLink is significantly less than convinced of that premise. … READ MORE …

Exactly who is doing your radical prostatectomy for you?

According to a newly published article in Urologic Oncology, at least 85 percent of all radical prostatectomies in America are now performed using robot-assisted laparoscopic prostatectomy (RALP). Actually, this is hardly a surprise. However, … READ MORE …

Neoadjuvant chemotherapy prior to surgery in higher-risk patients

A combined Russian and German research team has provided some interesting preliminary information on the use of neoadjuvant, low-dose docetaxel-based chemotherapy in treatment of intermediate- and high-risk patients prior to radical prostatectomy. … READ MORE …